🔗 Permalink

Assignee profile:

Deciphera Pharmaceuticals, LLC

City:

Waltham, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2026-04-16

Patent Grants:

Last grant date:

2026-06-02

Top Inventors for applications by Deciphera Pharmaceuticals, LLC

These are the the leading inventors for applications assigned to Deciphera Pharmaceuticals, LLC:

Michael D. Kaufman 24 Waltham, MA United States
Rodrigo Ruiz Soto 22 Waltham, MA United States
Corey Bloom 20 Bend, OR United States
Scott Bone 20 Bend, OR United States

Fred Jordan 20 Bend, OR United States
Oliver Rosen 18 Waltham, MA United States
Daniel L. Flynn 18 Waltham, MA United States
Jama Pitman 17 Waltham, MA United States

Bryan D. Smith 8 Waltham, MA United States
Yu Mi Ahn 8 Waltham, MA United States
Lakshminarayana Vogeti 6 Waltham, MA United States
Keisuke Kuida 5 Waltham, MA United States

Elena Kostik 4 Waltham, MA United States
Timothy Caldwell 4 Lawrence, KS United States
Anu Gupta 3 Waltham, MA United States
Ehab Hamed 2 Waltham, MA United States

Ann Gelormini 2 Waltham, MA United States
Daniel L. Flynn 2 Lawrence, KS United States
Jeffery Zwicker 2 Waltham, MA United States
Gada Al-Ani 2 Waltham, MA United States

Timothy Caldwell 2 Waltham, MA United States
Kristen Stoltz 2 Waltham, MA United States
Salim Javed 2 Waltham, MA United States
Patrick Kearney 2 Waltham, MA United States

Bertrand Le Bourdonnec 2 Waltham, MA United States
Bertrand LeBourdonnec 2 Waltham, MA United States
Bryan D. Smith 1 Lawrence, KS United States
Lakshminarayana Vogeti 1 Lawrence, KS United States

Sanja Matecic MUSANIC 1 Zagreb, Croatia
Yu Mi Ahn 1 Lawrence, KS United States
Michael D. Kaufman 1 Lawrence, KS United States
Xiaoyan Li 1 Lexington, MA United States

Gada AI-Ani 1 Waltham, MA United States
Lara Jurkovic 1 Pula, Croatia
Jing Wang 1 Waltham, MA United States
Valentina Travancic 1 Zagreb, Croatia

Recent patent applications by Deciphera Pharmaceuticals, LLC

Deciphera Pharmaceuticals, LLC based in Waltham, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-04-16 ✅ Patent 12,643,883 granted on 2026-06-02

US20260103452A1

Chemistry; metallurgy

SOLID STATE FORMS OF A KINASE INHIBITOR

#2 | 2026-02-05 ✅ Patent 12,582,655 granted on 2026-03-24

US20260034131A1

Human necessities

METHODS OF TREATING DISORDERS USING CSF1R INHIBITORS

#3 | 2025-12-04 ✅ Patent 12,617,775 granted on 2026-05-05

US20250368622A1

Chemistry; metallurgy

PROCESSES OF MAKING CSF-1R INHIBITORS AND METHODS OF USE THEREOF

#4 | 2025-12-04 ✅ Patent 12,509,443 granted on 2025-12-30

US20250368621A1

Chemistry; metallurgy

CSF-1R INHIBITORS AND METHODS OF USE THEREOF

#5 | 2025-11-27 ✅ Patent 12,551,483 granted on 2026-02-17

US20250360133A1

Human necessities

FORMULATIONS OF VIMSELTINIB

#6 | 2025-07-31 ✅ Patent 12,528,787 granted on 2026-01-20

US20250243182A1

Chemistry; metallurgy

SOLID STATE FORMS OF A KINASE INHIBITOR

#7 | 2025-06-26 ✅ Patent 12,485,120 granted on 2025-12-02

US20250205237A1

Human necessities

METHODS OF TREATING DISORDERS USING CSF1R INHIBITORS

#8 | 2025-06-26 ✅ Patent 12,447,149 granted on 2025-10-21

US20250205236A1

Human necessities

FORMULATIONS OF VIMSELTINIB

#9 | 2024-12-19 ✅ Patent 12,616,683 granted on 2026-05-05

US20240415818A1

Human necessities

COMBINATION THERAPY FOR THE TREATMENT OF GASTROINTESTINAL STROMAL TUMORS

#10 | 2024-11-28 ✅ Patent 12,213,968 granted on 2025-02-04

US20240390345A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#11 | 2024-11-28 ✅ Patent 12,226,406 granted on 2025-02-18

US20240390344A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#12 | 2024-11-28 ✅ Patent 12,213,967 granted on 2025-02-04

US20240390343A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#13 | 2024-10-24 ✅ Patent 12,318,374 granted on 2025-06-03

US20240350466A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#14 | 2024-10-17 ✅ Patent 12,318,373 granted on 2025-06-03

US20240342145A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#15 | 2024-10-17 ✅ Patent 12,295,944 granted on 2025-05-13

US20240342144A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#16 | 2024-05-09 ✅ Patent 12,023,328 granted on 2024-07-02

US20240148706A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#17 | 2024-04-18 ✅ Patent 11,969,415 granted on 2024-04-30

US20240122907A1

Human necessities

(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#18 | 2024-03-21 ✅ Patent 12,064,422 granted on 2024-08-20

US20240091206A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#19 | 2024-03-14 ✅ Patent 12,059,411 granted on 2024-08-13

US20240082227A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#20 | 2024-03-14 ✅ Patent 12,023,326 granted on 2024-07-02

US20240082226A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#21 | 2024-03-07 ✅ Patent 12,023,327 granted on 2024-07-02

US20240075020A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#22 | 2024-03-07 ✅ Patent 12,023,325 granted on 2024-07-02

US20240075019A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#23 | 2024-03-07 ✅ Patent 12,059,410 granted on 2024-08-13

US20240075018A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#24 | 2024-02-29 ✅ Patent 11,918,564 granted on 2024-03-05

US20240066013A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#25 | 2024-02-29 ✅ Patent 11,911,370 granted on 2024-02-27

US20240066012A1

Human necessities

COMPOSITIONS OF 1-(4-BROMO-5-(1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL)-2-FLUOROPHEYL)-3-PHENYLUREA

#26 | 2023-12-28 ✅ Patent 12,285,430 granted on 2025-04-29

US20230414614A1

Human necessities

Methods of treating disorders using CSF1R inhibitors

#27 | 2023-12-07 ✅ Patent 11,844,788 granted on 2023-12-19

US20230390258A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#28 | 2023-12-07 ✅ Patent 11,850,241 granted on 2023-12-26

US20230390257A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#29 | 2023-12-07 ✅ Patent 11,903,933 granted on 2024-02-20

US20230390256A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#30 | 2023-12-07 ✅ Patent 11,850,240 granted on 2023-12-26

US20230390255A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

#31 | 2023-11-30 ✅ Patent 12,577,249 granted on 2026-03-17

US20230382915A1

Chemistry; metallurgy

GCN2 AND PERK KINASE INHIBITORS AND METHODS OF USE THEREOF

#32 | 2023-10-26 ✅ Patent 12,377,097 granted on 2025-08-05

US20230338376A1

Human necessities

AMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

#33 | 2023-10-10 ✅ Patent 11,779,572 granted on 2023-10-10

US17938353

Human necessities

Methods of treating gastrointestinal stromal tumors

#34 | 2023-08-31 ✅ Patent 11,801,237 granted on 2023-10-31

US20230270728A1

Human necessities

Amorphous kinase inhibitor formulations and methods of use thereof

#35 | 2023-08-17 ✅ Patent 12,319,655 granted on 2025-06-03

US20230257352A1

Chemistry; metallurgy

RAF kinase inhibitors and methods of use thereof

#36 | 2023-06-29 ✅ Patent 11,793,795 granted on 2023-10-24

US20230201176A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

#37 | 2023-06-29 ✅ Patent 11,896,585 granted on 2024-02-13

US20230201175A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

#38 | 2023-05-11 ✅ Patent 11,813,251 granted on 2023-11-14

US20230145926A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#39 | 2023-02-16 ✅ Patent 12,479,833 granted on 2025-11-25

US20230047915A1

Chemistry; metallurgy

HETEROARYLAMINOPYRIMIDINE AMIDE AUTOPHAGY INHIBITORS AND METHODS OF USE THEREOF

#40 | 2023-02-09 ✅ Patent 12,071,432 granted on 2024-08-27

US20230039712A1

Chemistry; metallurgy

Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof

#41 | 2022-11-24 ✅ Patent 11,969,414 granted on 2024-04-30

US20220370426A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#42 | 2022-09-01 ✅ Patent 11,912,668 granted on 2024-02-27

US20220274934A1

Chemistry; metallurgy

GCN2 and perk kinase inhibitors and methods of use thereof

#43 | 2022-08-25 ✅ Patent 11,576,904 granted on 2023-02-14

US20220265621A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#44 | 2022-08-25 ✅ Patent 11,529,336 granted on 2022-12-20

US20220265620A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#45 | 2022-08-18 ✅ Patent 11,433,056 granted on 2022-09-06

US20220257575A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#46 | 2022-08-18 ✅ Patent 11,612,591 granted on 2023-03-28

US20220257574A1

Human necessities

Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea

#47 | 2022-08-04 ✅ Patent 11,534,432 granted on 2022-12-27

US20220241256A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#48 | 2022-06-23 ✅ Patent 12,414,955 granted on 2025-09-16

US20220193083A1

Human necessities

ANTI-VIRAL ACTIVITY OF VPS34 INHIBITORS

#49 | 2022-06-16 ✅ Patent 11,801,238 granted on 2023-10-31

US20220184050A1

Human necessities

Anti-viral activity of VPS34 inhibitors

#50 | 2022-05-12 ✅ Patent 12,509,456 granted on 2025-12-30

US20220144825A1

Chemistry; metallurgy

SOLID STATE FORMS OF RIPRETINIB

#51 | 2022-05-12 ✅ Patent 11,679,110 granted on 2023-06-20

US20220143018A1

Human necessities

Methods of treating disorders using CSF1R inhibitors

#52 | 2022-05-12 ✅ Patent 11,344,536 granted on 2022-05-31

US20220143008A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#53 | 2022-05-12 ✅ Patent 11,426,390 granted on 2022-08-30

US20220142997A1

Human necessities

Methods of treating gastrointestinal stromal tumors

#54 | 2022-02-03

US20220031678A1

Human necessities

USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA

#55 | 2022-02-03 ✅ Patent 11,576,903 granted on 2023-02-14